Liang Schweizer

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 3

Top Topics

Respiratory Syndrome Coronavirus

Highly Efficient

Top Venues

Science advances

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kathryn M Hastie, Haoyang Li, Daniel H Bedinger, Sharon L Schendel, S Moses Dennison, Kan Li, Vamseedhar Rayaprolu, Xiaoying Yu, Colin J Mann, Michelle A Zandonatti, Ruben Diaz Avalos, Dawid S Żyła, Tierra Buck, Sean Hui, Kelly Shaffer, Chitra Hariharan, Jieyun Yin, Eduardo Olmedillas, Adrian S Enriquez, Diptiben Parekh, Milite Abraha, Elizabeth Feeney, Gillian Q Horn, null null, Yoann Aldon, Hanif Ali, Sanja Aracic, Ronald R Cobb, Ross S Federman, Joseph M Fernandez, Jacob Glanville, Robin Green, Gevorg Grigoryan, Ana G Lujan Hernandez, David D Ho, Kuan-Ying A Huang, John Ingraham, Weidong Jiang, Paul Kellam, Cheolmin Kim, Minsoo Kim, Hyeong Mi Kim, Chao Kong, Shelly J Krebs, Fei Lan, Guojun Lang, Soo-Young Lee, Cheuk Lun Leung, Junli Liu, Yanan Lu, Anna J MacCamy, Andrew T McGuire, Anne L Palser, Terence Howard Rabbitts, Zahra R Tehrani, Mohammad M Sajadi, Rogier W Sanders, Aaron K Sato, Liang Schweizer, Ji-Min Seo, Bingqing Shen, Jonne L Snitselaar, Leonidas Stamatatos, Yongcong Tan, Milan T Tomic, Marit J VAN Gils, Sawsan Youssef, Jian Yu, Tom Z Yuan, Qian Zhang, Bjoern Peters, Georgia D Tomaras, Timothy Germann, Erica Ollmann Saphire
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science (New York, N.Y.) 374 (6566) (2021)
Yuan Wang, Ruina Jin, Bingqing Shen, Na Li, He Zhou, Wei Wang, Yingjie Zhao, Mengshi Huang, Pan Fang, Shanshan Wang, Pascaline Mary, Ruikun Wang, Peixiang Ma, Ruonan Li, Yujie Tian, Youjia Cao, Fubin Li, Liang Schweizer, Hongkai Zhang
High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics. Science advances 7 (24) (2021)
Yu Guo, Lisu Huang, Guangshun Zhang, Yanfeng Yao, He Zhou, Shu Shen, Bingqing Shen, Bo Li, Xin Li, Qian Zhang, Mingjie Chen, Da Chen, Jia Wu, Dan Fu, Xinxin Zeng, Mingfang Feng, Chunjiang Pi, Yuan Wang, Xingdong Zhou, Minmin Lu, Yarong Li, Yaohui Fang, Yun-Yueh Lu, Xue Hu, Shanshan Wang, Wanju Zhang, Ge Gao, Francisco Adrian, Qisheng Wang, Feng Yu, Yun Peng, Alexander G Gabibov, Juan Min, Yuhui Wang, Heyu Huang, Alexey V Stepanov, Wei Zhang, Yan Cai, Junwei Liu, Zhi-Ming Yuan, Chen Zhang, Zhiyong Lou, Fei Deng, Hongkai Zhang, Chao Shan, Liang Schweizer, Kun Sun, Zihe Rao
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes. Nature communications 12 (1) (2021)